Geron Corp (GERN)
3.785
+0.10
(+2.57%)
USD |
NASDAQ |
Apr 18, 11:02
Geron Cash from Financing (TTM): 362.02M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 362.02M |
September 30, 2023 | 340.66M |
June 30, 2023 | 316.09M |
March 31, 2023 | 368.31M |
December 31, 2022 | 87.26M |
September 30, 2022 | 94.98M |
June 30, 2022 | 90.20M |
March 31, 2022 | 32.29M |
December 31, 2021 | 48.56M |
September 30, 2021 | 28.34M |
June 30, 2021 | 52.31M |
March 31, 2021 | 183.92M |
December 31, 2020 | 168.35M |
September 30, 2020 | 179.20M |
June 30, 2020 | 164.21M |
March 31, 2020 | 20.18M |
December 31, 2019 | 19.50M |
September 30, 2019 | 9.235M |
June 30, 2019 | 9.338M |
March 31, 2019 | 91.42M |
December 31, 2018 | 92.97M |
September 30, 2018 | 94.03M |
June 30, 2018 | 84.95M |
March 31, 2018 | 2.664M |
December 31, 2017 | 1.111M |
Date | Value |
---|---|
September 30, 2017 | 0.049M |
June 30, 2017 | 0.139M |
March 31, 2017 | 0.343M |
December 31, 2016 | 1.169M |
September 30, 2016 | 1.967M |
June 30, 2016 | 2.087M |
March 31, 2016 | 1.924M |
December 31, 2015 | 2.575M |
September 30, 2015 | 2.295M |
June 30, 2015 | 2.19M |
March 31, 2015 | 2.217M |
December 31, 2014 | 98.36M |
September 30, 2014 | 103.89M |
June 30, 2014 | 104.22M |
March 31, 2014 | 104.16M |
December 31, 2013 | 6.553M |
September 30, 2013 | 0.563M |
June 30, 2013 | 0.131M |
March 31, 2013 | 0.161M |
December 31, 2012 | 0.15M |
September 30, 2012 | -4.109M |
June 30, 2012 | 0.177M |
March 31, 2012 | 0.242M |
December 31, 2011 | 0.386M |
September 30, 2011 | 98.46M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.235M
Minimum
Sep 2019
368.31M
Maximum
Mar 2023
135.52M
Average
90.20M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | 595.12M |
SELLAS Life Sciences Group Inc | 22.32M |
Johnson & Johnson | -15.82B |
Immuneering Corp | 28.44M |
Moderna Inc | -1.377B |